132 related articles for article (PubMed ID: 38018772)
21. [The safety and effect of transhepatic hilar approach for the treatment of bismuth type Ⅲ and Ⅳ hilar cholangiocarcinoma].
He M; Wang HL; Yan JY; Xu SW; Chen W; Wang J
Zhonghua Wai Ke Za Zhi; 2018 May; 56(5):360-366. PubMed ID: 29779312
[No Abstract] [Full Text] [Related]
22. Development and validation of a new prognostic immune-inflammatory-nutritional score for predicting outcomes after curative resection for intrahepatic cholangiocarcinoma: A multicenter study.
Zhu J; Wang D; Liu C; Huang R; Gao F; Feng X; Lan T; Li H; Wu H
Front Immunol; 2023; 14():1165510. PubMed ID: 37063918
[TBL] [Abstract][Full Text] [Related]
23. [Hilar cholangiocarcinoma -- results of en bloc resection of tumor and liver].
Otto G; Thies J; Hoppe-Lotichius M; Bittinger F; Pitton MB; Hadian A
Chirurg; 2004 Jan; 75(1):59-65. PubMed ID: 14740129
[TBL] [Abstract][Full Text] [Related]
24. Surgical resection for hilar cholangiocarcinoma: experience improves resectability.
Cannon RM; Brock G; Buell JF
HPB (Oxford); 2012 Feb; 14(2):142-9. PubMed ID: 22221577
[TBL] [Abstract][Full Text] [Related]
25. [A multicenter clinical analysis of short-term efficacy of laparoscopic radical resection of hilar cholangiocarcinoma].
Xu J; Xiong YF; Huang XJ; Yang FC; Li JD; Liu JH; Zhao WX; Qin RY; Yin XM; Zheng SG; Liang X; Peng B; Zhang QF; Li DW; Tang ZH
Zhonghua Wai Ke Za Zhi; 2020 Oct; 58(10):758-764. PubMed ID: 32993262
[No Abstract] [Full Text] [Related]
26. Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China.
Hu HJ; Mao H; Shrestha A; Tan YQ; Ma WJ; Yang Q; Wang JK; Cheng NS; Li FY
World J Gastroenterol; 2016 Feb; 22(8):2601-10. PubMed ID: 26937148
[TBL] [Abstract][Full Text] [Related]
27. Predictive value of HTS grade in patients with intrahepatic cholangiocarcinoma undergoing radical resection: a multicenter study from China.
Huang G; Zhang H; Yang Z; Li Q; Yuan H; Chen P; Xie C; Meng B; Zhang X; Chen K; Yu H
World J Surg Oncol; 2024 Jan; 22(1):17. PubMed ID: 38200585
[TBL] [Abstract][Full Text] [Related]
28. Age-adjusted Charlson Comorbidity Index predicts survival in intrahepatic cholangiocarcinoma patients after curative resection.
Qu WF; Zhou PY; Liu WR; Tian MX; Jin L; Jiang XF; Wang H; Tao CY; Fang Y; Zhou YF; Song SS; Ding ZB; Peng YF; Dai Z; Qiu SJ; Zhou J; Fan J; Tang Z; Shi YH
Ann Transl Med; 2020 Apr; 8(7):487. PubMed ID: 32395531
[TBL] [Abstract][Full Text] [Related]
29. Left hepatectomy combined with hepatic artery resection for hilar cholangiocarcinoma: A retrospective cohort study.
Peng C; Li C; Wen T; Yan L; Li B
Int J Surg; 2016 Aug; 32():167-73. PubMed ID: 27344254
[TBL] [Abstract][Full Text] [Related]
30. Age-adjusted Charlson Comorbidity Index (ACCI) is a significant factor for predicting survival after radical gastrectomy in patients with gastric cancer.
Lin JX; Huang YQ; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Li P; Huang CM; Zheng CH
BMC Surg; 2019 May; 19(1):53. PubMed ID: 31133008
[TBL] [Abstract][Full Text] [Related]
31. Evolution of surgery for Klatskin tumor demonstrates improved outcome: a single center analysis.
Yan Y; Lu N; Tian W; Liu T
Tumori; 2014; 100(6):e250-6. PubMed ID: 25688507
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of Four Lymph Node Classifications for the Prediction of Survival in Hilar Cholangiocarcinoma.
Liu ZP; Zhang QY; Chen WY; Huang YY; Zhang YQ; Gong Y; Jiang Y; Bai J; Chen ZY; Dai HS
J Gastrointest Surg; 2022 May; 26(5):1030-1040. PubMed ID: 34973138
[TBL] [Abstract][Full Text] [Related]
33. A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience.
Hyder O; Marques H; Pulitano C; Marsh JW; Alexandrescu S; Bauer TW; Gamblin TC; Sotiropoulos GC; Paul A; Barroso E; Clary BM; Aldrighetti L; Ferrone CR; Zhu AX; Popescu I; Gigot JF; Mentha G; Feng S; Pawlik TM
JAMA Surg; 2014 May; 149(5):432-8. PubMed ID: 24599477
[TBL] [Abstract][Full Text] [Related]
34. [Clinical application of combined hepatic artery resection and reconstruction in surgical treatment for hilar cholangiocarcinoma].
Dai HS; Bie P; Wang SG; He Y; Li DJ; Tian F; Zhao X; Chen ZY
Zhonghua Wai Ke Za Zhi; 2018 Jan; 56(1):41-46. PubMed ID: 29325352
[No Abstract] [Full Text] [Related]
35. Prognosis and Circumferential Margin in Patients with Resected Hilar Cholangiocarcinoma.
Stremitzer S; Stift J; Laengle J; Schwarz C; Kaczirek K; Jones RP; Quinn LM; Fenwick SW; Diaz-Nieto R; Poston GJ; Malik HZ
Ann Surg Oncol; 2021 Mar; 28(3):1493-1498. PubMed ID: 32914390
[TBL] [Abstract][Full Text] [Related]
36. Defining Early Recurrence of Hilar Cholangiocarcinoma After Curative-intent Surgery: A Multi-institutional Study from the US Extrahepatic Biliary Malignancy Consortium.
Zhang XF; Beal EW; Chakedis J; Chen Q; Lv Y; Ethun CG; Salem A; Weber SM; Tran T; Poultsides G; Son AY; Hatzaras I; Jin L; Fields RC; Buettner S; Scoggins C; Martin RCG; Isom CA; Idrees K; Mogal HD; Shen P; Maithel SK; Schmidt CR; Pawlik TM
World J Surg; 2018 Sep; 42(9):2919-2929. PubMed ID: 29404753
[TBL] [Abstract][Full Text] [Related]
37. The Clinical Impact of the Age-adjusted Charlson Comorbidity Index on Esophageal Cancer Patients Who Receive Curative Treatment.
Aoyama T; Atsumi Y; Kawahara S; Tamagawa H; Tamagawa A; Ozawa Y; Maezawa Y; Kano K; Murakawa M; Kazama K; Segami K; Hara K; Numata M; Oshima T; Yukawa N; Masuda M; Rino Y
In Vivo; 2020; 34(5):2783-2790. PubMed ID: 32871815
[TBL] [Abstract][Full Text] [Related]
38. Predictive value of the Age-Adjusted Charlson Comorbidity Index on perioperative complications and survival in patients undergoing primary debulking surgery for advanced epithelial ovarian cancer.
Suidan RS; Leitao MM; Zivanovic O; Gardner GJ; Long Roche KC; Sonoda Y; Levine DA; Jewell EL; Brown CL; Abu-Rustum NR; Charlson ME; Chi DS
Gynecol Oncol; 2015 Aug; 138(2):246-51. PubMed ID: 26037900
[TBL] [Abstract][Full Text] [Related]
39. Effect of the Age-Adjusted Charlson Comorbidity Index on the Survival of Esophageal Squamous Cell Carcinoma Patients after Radical Esophagectomy.
Song J; Lin Y; Zhang J; Liu S; Zhou J; Zeng Q; Lin Z; Fu R; Qiu M; Hu Z
J Clin Med; 2022 Nov; 11(22):. PubMed ID: 36431214
[TBL] [Abstract][Full Text] [Related]
40. Transhepatic hilar approach for Bismuth types III and IV perihilar cholangiocarcinoma with long-term outcomes.
Xu X; Yang L; Chen W; He M
J Int Med Res; 2021 May; 49(5):3000605211008336. PubMed ID: 33983055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
